MannKind Announces Renewal of Shelf Registration and ATM Agreements

VALENCIA, Calif., Sept. 4, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation MNKD today announced the renewal of its shelf Registration Statement on Form S-3, as filed with the Securities and Exchange Commission, replacing the previous shelf which expired on August 31, 2015. Concurrently, MannKind also renewed its At-The-Market Issuance Sales Agreements with Meyers Associates, L.P. (now doing business as BP Capital, a division of Meyers Associates, L.P.) and with MLV & Co. LLC providing for sales, from time to time, of the Company's common stock. 

About MannKind Corporation

MannKind Corporation MNKD focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes. MannKind maintains a website at http://www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.